Bluejay Diagnostics, Inc.
Symphony IL-6 is a device that quantitates human IL-6 by fluorescence enzyme immunoassay (FEIA) from whole-blood specimens. Use of Symphony IL- 6 removes the need for plasma separation before testing. Symphony IL-6 comprises two components, the Symphony Fluorescence Immunoanalyzer and the Symphony IL-6 Cartridge. Whole blood is added to the cartridge and then up to six cartridges can be inserted into the immunoanalyzer. After 20 minutes a readout and printout are given with a quantitative IL-6 concentration. The used cartridges are fully enclosed and can be easily disposed of in general hospital bio-waste. Given the nature of this device and its portability, there is potential for future deployment in a near patient setting. This study is to establish an interleukin-6 (IL-6) cutoff value using the Symphony IL-6 test for patients at high risk of severe sepsis caused by a COVID-19 and/or influenza infection.
Severe sepsis
| Study Type : | OBSERVATIONAL |
| Estimated Enrollment : | 200 participants |
| Official Title : | Symphony IL-6 Study in Patients at Risk of Severe Sepsis Due to COVID-19 and/or Influenza Infection |
| Actual Study Start Date : | 2022-11-22 |
| Estimated Primary Completion Date : | 2024-08-21 |
| Estimated Study Completion Date : | 2024-11-21 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 22 Years |
| Sexes Eligible for Study: | ALL |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
University of Michigan Medical Center
Ann Arbor, Road cancer, United States, 48109